Neuropsychopharmacology
- Amplitude-determined seizure-threshold, electric field modeling, and electroconvulsive therapy antidepressant and cognitive outcomes2 years ago
- Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT2A receptor the unique player?2 years ago
- Effects of open access publishing on article metrics in Neuropsychopharmacology2 years ago
- Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder2 years ago
- Neurogenesis-independent mechanisms of MRI-detectable hippocampal volume increase following electroconvulsive stimulation2 years ago
- Advances in precision neuromodulation: electroconvulsive therapy amplitude titration2 years ago
- Academic ethics of mental health: the national black postdocs framework for the addressment of support for undergraduate and graduate trainees2 years ago
Journal of Psychopharmacology
- Effectiveness of vortioxetine in patients with major depressive disorder comorbid with generalized anxiety disorder: Results of the RECONNECT study3 years ago
- Differences in social brain function in autism spectrum disorder are linked to the serotonin transporter: A randomised placebo-controlled single-dose crossover trial3 years ago
- Regulation of clock and clock-controlled genes during morphine reward and reinforcement: Involvement of the period 2 circadian clock3 years ago
- The effects of selective serotonin reuptake inhibitors on memory functioning in older adults: A systematic literature review3 years ago
- Patient perspectives of lithium and quetiapine augmentation treatment in treatment-resistant depression: A qualitative assessment3 years ago
- A letter to the editor, associated with the article entitled “Efficacy and tolerability of combination treatments for major depression: Antidepressants plus second-generation antipsychotics vs esketamine vs lithium” by Vázquez et al. (Journal of Psychopharmacology, 2021, Vol. 35(8) 890–900)3 years ago
- Hyodeoxycholic acid inhibits lipopolysaccharide-induced microglia inflammatory responses through regulating TGR5/AKT/NF-κB signaling pathway3 years ago
European Neuropsychopharmacology
- Contents3 years ago
- ECNP Calendar of Meetings3 years ago
- Psychotropic drug repurposing for COVID-19: a Systematic Review and Meta-Analysis3 years ago
- Primary prevention in psychiatry is not science fiction3 years ago
- Long-term methylphenidate exposure and 24-hours blood pressure and left ventricular mass in adolescents and young adults with attention deficit hyperactivity disorder3 years ago
- Stress, mental disorder and ketamine as a novel, rapid acting treatment3 years ago
- Corrigendum to ‘No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial’ [European Neuropsychopharmacology 53 (2021) 34–46]3 years ago
Psychopharmacology
- Pulsed nicotine infusions as a model for smoking: validating a tool to explore nicotine thresholds in humans1 year ago
- Pulsed nicotine infusions as a model for smoking: validating a tool to explore nicotine thresholds in humans1 year ago
- Reinforcing effects of fentanyl analogs found in illicit drug markets1 year ago
- Reinforcing effects of fentanyl analogs found in illicit drug markets1 year ago
- Unraveling psilocybin’s therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression1 year ago
- Unraveling psilocybin’s therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression1 year ago
- Sex differences in behavior, cognitive, and physiological recovery following methamphetamine administration1 year ago
International Journal of Neuropsychopharmacology
- 451. REVEALING NOVEL BIOMARKERS AND THERAPEUTIC TARGETS GENE IN SCHIZOPHRENIA A BIOINFORMATIC STUDY THROUGH PROTEIN-PROTEIN INTERACTION NETWORK ANALYSIS1 week ago
- Correction to: Inflammation and Blood-Brain Barrier in Depression: Interaction of CLDN5 and IL6 Gene Variants in Stress-Induced Depression1 month ago
- Correction to: From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trials1 month ago
- Frequent vocalizations and deep brain stimulation-responsive hyperkinesia in a striatal disinhibition rat model for Tourette syndrome3 months ago
- Exploring the influence of synaptic density and anxiety on pain perception: evidence from a [11C]UCB-J positron emission tomography imaging study3 months ago
- NMDA receptor involvement in dopaminergic modulation of neuroplasticity induced by paired associative stimulation3 months ago
- Pharmacological modulation of directed network communication and neural hubs in action–effect integration3 months ago
Frontiers in Pharmacology
- Intravenous Reelin rescues despair-like behavior, Reelin cells in the dentate sub-granular zone, and spleen atrophy in the cyclic corticosterone model of recurring depressive episodes2 years ago
- Dl-3-n-butylphthalide attenuates cerebral ischemia/reperfusion injury in mice through AMPK-mediated mitochondrial fusion2 years ago
- Neurovascular effects of cocaine: relevance to addiction2 years ago
- Established and emerging GABAA receptor pharmacotherapy for epilepsy2 years ago
- Probiotics as modulators of gut-brain axis for cognitive development2 years ago
- The transmembrane channel-like 6 (TMC6) in primary sensory neurons involving thermal sensation via modulating M channels2 years ago
- Gene editing improves endoplasmic reticulum-mitochondrial contacts and unfolded protein response in Friedreich’s ataxia iPSC-derived neurons2 years ago
Translational Psychiatry
- Genetic and clinical correlates of two neuroanatomical AI dimensions in the Alzheimer’s disease continuum11 months ago
- Deciphering autism heterogeneity: a molecular stratification approach in four mouse models11 months ago
- Cortical kappa opioid receptors integrate negative affect and sleep disturbance11 months ago
- Oral antioxidant edaravone protects against cognitive deficits induced by chronic hypobaric hypoxia at high altitudes11 months ago
- Discovery of novel protective agents for infection-related delirium through bispectral electroencephalography11 months ago
- Serum cytokines and inflammatory proteins in individuals with heroin use disorder: potential mechanistically based biomarkers for diagnosis11 months ago
- Quantitative proteomics combined independent PRM analysis reveals the mitochondrial and synaptic mechanism underlying norisoboldine’s antidepressant effects11 months ago
Molecular Psychiatry
- Embryo-restricted responses to maternal IL-17A promote neurodevelopmental disorders in mouse offspring11 months ago
- Leveraging pleiotropy for the improved treatment of psychiatric disorders11 months ago
- Prenatal and early childhood infections requiring hospitalization and risk of neurodevelopmental disorders in offspring: a population-based birth cohort study in Taiwan11 months ago
- Sex/gender effects of glial reactivity on preclinical Alzheimer’s disease pathology11 months ago
- Meeting report for the 2024 UC Irvine Center for neural circuit mapping conference: Brain cell types, circuits, and disorders11 months ago
- Heparin treatment is associated with a delayed diagnosis of Alzheimer’s dementia in electronic health records from two large United States health systems11 months ago
- 11C-UCB-J PET imaging is consistent with lower synaptic density in autistic adults11 months ago
Nature Reviews Neuroscience
CNS Spectrum
- Reduced Healthcare Resource Utilization in Patients With Chronic Insomnia 24 Months After Treatment With Digital CBT-I: A Matched-Control Study2 years ago
- Patient and Staff Attitudes Toward Clothing Restrictions on a Pediatric Psychiatric Unit2 years ago
- AI-Based Adherence Prediction for Patients: Leveraging a Mobile Application to Improve Clinical Trials2 years ago
- Lumateperone in Pooled Late-Phase Schizophrenia Trials: Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed2 years ago
- A Prospective Observational Study Examining the Real-World Clinical and Treatment Outcomes of Parkinson’s Disease Psychosis in the United States2 years ago
- Prevention in Practice: Improving Communication on the Benefits of Treatments for Schizophrenia2 years ago
- Vilazodone-Induced Glycolimia2 years ago
Neuropharmacology
- Neurolipidomics in schizophrenia: A not so well-oiled machine12 months ago
- Ligand bias at the muscarinic acetylcholine receptor family: opportunities and challenges1 year ago
- Activation of μ receptors by SR-17018 through a distinctive mechanism1 year ago
- Empathic pain: Exploring the multidimensional impacts of biological and social aspects in pain1 year ago
- Neuronostatin regulates neuronal function and energetic metabolism in Alzheimer’s disease in a GPR107–dependent manner1 year ago
- Corrigendum to “PGC-1α in the hippocampus mediates depressive-like and stress-coping behaviours and regulates excitatory synapses in the dentate gyrus in mice” [Neuropharmacology 250 (2024) 109908]1 year ago
- Implications of Liquid-Liquid Phase Separation and Ferroptosis in Alzheimer’s Disease1 year ago
Nature
- Researchers in dismay as US exits world science body UNESCO . . . again1 month ago
- AI for Latin inscriptions supplies missing text and predicts date and location1 month ago
- Global hotspots of mycorrhizal fungal richness are poorly protected1 month ago
- Daily briefing: Scans reveal that optimists share similar brain-activity patterns1 month ago
- Superheating gold beyond the predicted entropy catastrophe threshold1 month ago
- Hippocampal representations drift in stable multisensory environments1 month ago
- China’s fossil-fuel challenge — how to build a bridge to renewables1 month ago